412
Participants
Start Date
July 29, 2020
Primary Completion Date
October 8, 2021
Study Completion Date
October 22, 2021
Vitamins
2 tablets daily from the first day (day 0) to day 9
Telmisartan
1 tablet daily from the first day (day 0) to day 9
Ciclesonide
2 puffs twice a day in an inhalation chamber from the first day (day 0) to day 9
interferon β-1b
A 10-minute nebulization, once a day, from the first day (day 0) to day 4, of 9.6 MIU / 300 µg of IFN-β-1b (EXTAVIA®) diluted in 2 mL of water
Bordeaux university Hospital, Bordeaux
CHU de Montpellier, Montpellier
Groupe hospitalier Paris Saint Joseph, Paris
CHU de Dijon-Bourgogne, Dijon
CHRU de Nancy, Nancy
CNGE, Paris
CHU de Toulouse, Toulouse
University of Bordeaux
OTHER
University Hospital, Bordeaux
OTHER